News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
OncoInfluencers to Follow on Social Media: Dr. Arndt Vogel
Dec 2, 2024, 13:53

OncoInfluencers to Follow on Social Media: Dr. Arndt Vogel

We’re excited to feature Dr. Arndt Vogel, a distinguished leader in gastrointestinal cancer research and treatment, as our next oncoinfluencer.

About Arndt Vogel

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.

Dr. Arndt Vogel is an active presence on social media, regularly sharing his expertise on gastrointestinal cancer treatment, emerging clinical trials, and advancements in personalized medicine. His posts on X/Twitter and LinkedIn offer valuable updates on the latest breakthroughs in GI cancer research, hepatobiliary malignancies, and the future of cancer care.

Follow Dr. Arndt Vogel on X/Twitter and LinkedIn to stay updated on his pioneering research and contributions to the field of gastrointestinal oncology.

Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.

Arndt Vogel cancer gastrointestinal cancer research Hannover Medical School LinkedIn OncoDaily OncoInfluencers Oncoinfluencers to Follow on Social Media Oncology X
Special Coverage
Blog
Dec 2, 2024, 13:53
OncoInfluencers to Follow on Social Media: Dr. Arndt Vogel
Blog
Dec 2, 2024, 13:48
Janice Cowden: Excited to share that I’ve been invited to serve as a social media ambassador at SABCS 2024
Blog
Dec 2, 2024, 13:36
Sebastian Szmit: Guidelines of Polish Lipid Society regarding the diagnosis and treatment of lipid disorders
Blog
Dec 2, 2024, 13:36
Systematic Review and Meta-Analysis of Locoregional Therapies for HCC summarized by Arndt Vogel
Insight
Dec 2, 2024, 13:13
Supriya Peshin: Exploring the pivotal role of the ESoPEC trial in advancing esophageal cancer treatment
Blog
Dec 2, 2024, 13:12
Kingsley Ndoh: Honored to have contributed to the 2024 President's Cancer Panel’s report
Blog
Dec 2, 2024, 13:08
Lacy Hubbard: Honored to participate in the Continental Consultative Meeting to Eliminate Cervical Cancer in Africa
Career
Dec 2, 2024, 13:05
Guru Sonpavde: Job opportunity for a medical oncologist to join AdventHealth Central Florida's GU Program
Blog
Dec 2, 2024, 13:02
Marco Donia: Pleased to join Lukas Jeker at the Basel Cell Therapy Symposium
Insight
Dec 2, 2024, 12:44
Myeloma Paper of the Day, December 2nd, suggested by Robert Orlowski
Insight
Dec 2, 2024, 12:39
Nirmala Bhoo Pathy: 50 years of public health training in Malaysia
Blog
Dec 2, 2024, 12:36
On the way to the AsBIC11 - The Babak Lab